| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_CADPS2_0014600 | Exon-Exon | chr7:122153303-122261771 | chr7:122513249-122621717 | 73 nt | 0.3699 |
| hsa_CADPS2_0014700 | Exon-Exon | chr7:122153303-122269382 | chr7:122513249-122629328 | 87 nt | 0.4943 |
| hsa_CADPS2_0013800 | Intron-Exon-Intron | chr7:122153303-122293294 | chr7:122513249-122653240 | 250 nt | 0.3440 |
| hsa_CADPS2_0013900 | Intron-Exon-Intron | chr7:122153303-122325410 | chr7:122513249-122685356 | 250 nt | 0.3280 |
| hsa_CADPS2_0014800 | Intron-Exon-Intron | chr7:122170186-122221344 | chr7:122530132-122581290 | 118 nt | 0.5169 |
| hsa_CADPS2_0014900 | Intron-Exon-Intron | chr7:122170186-122261771 | chr7:122530132-122621717 | 213 nt | 0.3850 |
| hsa_CADPS2_0015100 | Intron-Exon-Intron | chr7:122181459-122221344 | chr7:122541405-122581290 | 252 nt | 0.4444 |
| hsa_CADPS2_0015200 | Intron-Exon-Intron | chr7:122181459-122261771 | chr7:122541405-122621717 | 821 nt | 0.4214 |
| hsa_CADPS2_0015000 | Intron-Exon-Intron | chr7:122181459-122303623 | chr7:122541405-122663569 | 250 nt | 0.3960 |
| hsa_chr7_0099800 | Intergenic-Intergenic | chr7:122183026-122205733 | chr7:122542972-122565679 | 272 nt | 0.3603 |
A review of studies in humans, mice, and rats indicates that the circCADPS2 demonstrates stable expression in myocardial tissue and body fluids, with specific expression patterns associated with sudden cardiac death-related diseases [Tian et al. DOI:10.3390/molecules26041155]. A study in human traumatic brain injury (TBI) patients identified the circCADPS2 as a top up-regulated circular RNA (fold change 17.62) in brain injury tissues compared to adjacent contusion tissues, with its increased expression validated by qRT-PCR [Li et al. DOI:10.3389/fneur.2022.1086553].